Zika Virus

News and Video Search Results

News coverage

Blood Screening Market to Grow at CAGR of 11.6% through 2033; High Investment in Blood Transfusion Services to Bolster Growth

GlobeNewswire 18 Apr 2024

The blood screening market size is anticipated to grow from USD 2.99 Billion in 2023 to USD 8.96 Billion in 10 years. The market..

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
GlobeNewswire 04 Apr 2024
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
GlobeNewswire 26 Mar 2024
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
GlobeNewswire 25 Mar 2024
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.
GlobeNewswire 21 Mar 2024

0 shares 1 views

You might like

Zika Virus media coverage

Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook

GlobeNewswire 20 Mar 2024

*Total revenues of €153.7 million, including product sales of €144.6 million*

· Product sales surpassed..

Asia Pacific Preventive Vaccines Market to Hit Valuation of USD 63.11 Billion by 2032: Astute Analytica
GlobeNewswire 18 Mar 2024
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
GlobeNewswire 18 Mar 2024
Zika virus vaccine emerges as an unlikely hero in battling brain cancer
Science Daily 08 Mar 2024
Latin America Point of Care Diagnostics Market Growth Forecast Through 2030
GlobeNewswire 05 Mar 2024

Advertisement

More coverage

Baculovirus Expression System Market projected to reach USD 522.7 Million by 2030, growing at a CAGR of 7.5% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study

GlobeNewswire 05 Mar 2024

The Global Baculovirus Expression System Market was valued USD 315.3 Million in 2023 and projected to reach USD 522.7 Million by..

Zika vaccine safe, effective when administered during pregnancy
Science Daily 04 Mar 2024
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire 04 Mar 2024
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®
GlobeNewswire 29 Feb 2024
Vaccine Adjuvants Market Global Industry Analysis 2018-2028: Expanding Human Vaccine Adjuvants Segment and Rising Infectious Disease Threats Propel Market Advancements
GlobeNewswire 21 Feb 2024